Observational studyCardiology journal2026
Predictive factors for new-onset atrial fibrillation in patients with embolic stroke of undetermined source and left atrial enlargement - development of a risk score.
Observational study in Cardiology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn patients with embolic stroke of undetermined source (ESUS), detecting new-onset atrial fibrillation (AF) is crucial because it leads to treatment change and reduces stroke recurrence and mortality. However, the high cost and relatively low AF detection rate of implantable cardiac monitors (ICM) necessitate the identification of predictive factors to better select candidates. This study aimed to identify AF predictors in ESUS patients with left atrial enlargement (LAE) to improve ICM selection.
methodsWe conducted a retrospective observational study with consecutive patients with ESUS and LAE admitted to a tertiary hospital. Echocardiographic, electrocardiographic, and 24-hour Holter electrocardiogram (ECG) findings were collected and analyzed using multivariate logistic regression and cross-validation techniques. Independent predictors were incorporated into a risk model classifying patients into low-, moderate-, and high-risk categories for new-onset AF.
resultsA total of 100 patients were included. After an 18-month follow-up period, new-onset AF was detected in 19 patients (20%). Independent predictors included severe LAE (odds ratio [OR] 4.80, 95% confidence interval [CI] 1.32-17.37; p = 0.017), interatrial block (OR 6.22, 95% CI 1.27-30.47; p = 0.024), and atrial tachycardia ≥ 20 beats on 24-hour Holter-ECG (OR 7.62, 95% CI 1.21-47.74; p = 0.03). A predictive risk score (area under the curve [AUC] 0.733; p < 0.001) was developed, classifying patients into low (9.67% risk), moderate (36.6%), and high (100%) risk categories.
conclusionsInteratrial block (IAB), atrial tachycardia (AT) ≥ 20 beats, and severe LAE are strong new-onset AF predictors in ESUS patients with LAE. A new scoring system effectively stratifies AF risk, optimizing ICM selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.